08:00 , Feb 25, 2013 |  BC Week In Review  |  Financial News

Biosynex completes private placement

Biosynex S.A. (Euronext:ALBIO), Strasbourg, France   Business: Diagnostic   Date completed: 2/20/13   Type: Private placement   Raised: €500,003 ($667,954)   Shares: 70,822   Price: €7.06 ($9.43)   Shares after offering: 1.2 million   Investors:...
08:00 , Dec 19, 2011 |  BC Week In Review  |  Company News

Biosynex diagnostic news

Biosynex was awarded a contract to develop a diagnostic for the French army to detect Dengue Fever, West Nile virus (WNV), tick-borne encephalitis, Japanese encephalitis (JE) and yellow fever. The company plans to launch the...